Showing 1 to 2 of 2 clinical trials
CLINICAL TRIALS Trial No ClinicalTrials.gov ID |
Phase | Coordinator | |
---|---|---|---|
An International, Phase 3, Randomized, Multicenter, Open-label Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With KIT Exon 11 and Co-occurring KIT Exons 17 and/or 18 Mutations Who Were Previously Treated With Imatinib
INSIGHT NCT05734105 ![]() |
CENTRE UNIVERSITAIRE DE SANTE MCGILL![]() |
Alina Lungescu 514-934-1934 |
|
A Phase 3 Randomized, Open-Label, Multicenter Clinical Study of CGT9486+Sunitinib vs. Sunitinib in Subjects With Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors
Peak NCT05208047 ![]() |
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL![]() |
Samara Bloom 514-252-3400 poste 6244 |